Replies to post #223115 on Biotech Values

[chantillylive]

ABUS

Dew:

Thank you for your response.
DD to do...

r.
cl

[DewDiligence]

Quiz—What’s wrong with this PR from ABUS?

https://globenewswire.com/news-release/2019/03/04/1746016/0/en/Arbutus-to-Present-at-Cowen-Health-Care-Conference.html

WARMINSTER, Pa., March 04, 2019 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced that Dr. Mark Murray, Arbutus’ President and CEO, will present a corporate overview and business update at the Cowen Health Care Conference on Monday, March 11, 2019 at 2:50 PM EST in Boston.

[DewDiligence]

ABUS 12/31/18 cash=$124.6M—2019 burn guidance=$70-75M:

https://investor.arbutusbio.com/news-releases/news-release-details/arbutus-reports-fourth-quarter-and-year-end-2018-financial

[DewDiligence]

ABUS 1Q19 results:

https://investor.arbutusbio.com/news-releases/news-release-details/arbutus-reports-first-quarter-2019-financial-results-and

3/31/19 cash was $110.6M. 1Q19 operating cash burn was $16.5M, slightly below the run rate of the company’s guidance for 2019 cash burn of $70-75M.

During 1Q19, ABUS sold $2.6M of stock under its ATM facility. As of 3/31/19, there were 86M fully-diluted shares.